← back to search

Ke Yu

University of Science and Technology of China · CN
Area of research
Immunology · Molecular Biology
Research interest
Research interests include Metabolomics and Mass Spectrometry Studies, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, and Adipokines, Inflammation, and Metabolic Diseases.
h-index
14
citations
1,421
works
51
NIH funding
primary concept
email

Recent publications

Characteristics and anatomic location of PD-1 <sup>+</sup> TCF1 <sup>+</sup> stem-like CD8 T cells in chronic viral infection and cancer
Proceedings of the National Academy of Sciences 2023cited by 73position: middledoi
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
Proceedings of the National Academy of Sciences 2017cited by 873position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alice O. Kamphorst · Tisch Cancer Institute2 papers (2017–2023)Rafi Ahmed · Emory University2 papers (2017–2023)Gabriel Sica · Emory University2 papers (2017–2023)Tahseen H. Nasti · Emory University2 papers (2017–2023)Suresh S. Ramalingam · Emory University2 papers (2017–2023)Hong Wu · National Yang Ming Chiao Tung University1 papers (2017–2017)Shu Yang · Kunming Medical University1 papers (2017–2017)Nikita Patel · Indian Institute of Management Raipur1 papers (2017–2017)Rathi N. Pillai · Emory University1 papers (2017–2017)Madhusmita Behera · Emory University1 papers (2017–2017)Jennifer W. Carlisle · Emory University1 papers (2023–2023)Taofeek K. Owonikoko · New Mexico Cancer Center1 papers (2017–2017)Sivaram Gunisetty · Emory University1 papers (2023–2023) · 1 papers (2023–2023)Rebecca C. Obeng · University Hospitals of Cleveland1 papers (2023–2023)Helder I. Nakaya · Universidade de São Paulo1 papers (2023–2023)Lydia Koenig · Mayo Clinic in Arizona1 papers (2017–2017)Zhengjia Chen · University of Illinois Chicago1 papers (2017–2017)Daniel T. McManus · Emory University1 papers (2023–2023)Fadlo R. Khuri · Emory University1 papers (2017–2017)